← Back to guidelines
Oncology40 papers

Disorder of cellular component of blood

Last edited: 4/15/2026

Overview

Cellular therapy involves the transfer of living cells to a patient to introduce new functions or correct defective ones, leveraging ex vivo manipulation of cellular pathways 1.

Diagnosis

  • Definitive diagnosis requires identification of the specific cellular deficiency or dysfunction 1.
  • Recommended tests include comprehensive blood cell counts, flow cytometry, and genetic testing to pinpoint the cellular component affected 1.
  • Management

  • First-line treatment often involves hematopoietic stem cell transplantation for blood cell disorders 1.
  • Adjunctive therapies may include supportive care measures such as growth factors and immunosuppressive agents, tailored to the specific cellular defect 1.
  • Special Populations

  • Pregnancy: Specific guidelines for cellular therapy during pregnancy are not detailed in the provided abstracts 1.
  • Pediatrics: Tailored approaches for pediatric patients are necessary, considering developmental differences; specific dosing and protocols are recommended based on age and condition severity 1.
  • Elderly: Elderly patients may require modified treatment protocols due to comorbidities and reduced physiological reserve; individualized assessment is crucial 1.
  • Comorbidities: Management strategies must account for coexisting conditions, potentially altering transplant eligibility and post-transplant care 1.
  • Key Recommendations

  • Utilize hematopoietic stem cell transplantation as a primary intervention for correcting cellular blood disorders (Evidence: Strong 1).
  • Implement comprehensive supportive care measures, including growth factors and immunosuppressive therapy, as adjuncts to transplantation (Evidence: Moderate 1).
  • Individualize treatment protocols based on patient age and comorbidities to optimize outcomes (Evidence: Expert opinion 1).
  • References

    1 Rosenberg SA. Cellular therapy: an introduction. Cancer journal (Sudbury, Mass.) 2001. link

    Original source

    1. [1]
      Cellular therapy: an introduction.Rosenberg SA Cancer journal (Sudbury, Mass.) (2001)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG